Novel organotypic culture model of cholangiocarcinoma progression

Hepatology Research

Volumn 42, Issue 11, 2012, Pages 1119-1130

  Campbell, Deanna J W ^a   Dumur, Catherine I ^a   Lamour, Nadia F ^a   Dewitt, Jennifer L ^a   Sirica, Alphonse E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 D co culture; Cancer associated fibroblasts; Cholangiocarcinoma cell migration invasion; Gene expression profiling; Malignant cholangiocytes; Orthotopic rat cholangiocarcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; COLLAGEN GEL; COLLAGEN TYPE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CANCER SURVIVAL; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STROMA; TUMOR MICROENVIRONMENT;

EID: 84868013949     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01026.x     Document Type: Article

References (27)

1. Terada T, Makimoto K, Terayama N etal. Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 1996; 24: 706-12.
2. Okamura N, Yoshida M, Shibuya A etal. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 2005; 55: 724-31.
3. Sirica AE, Dumur CI, Campbell DJ etal. Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. Clin Gastroenterol Hepatol 2009; 7: S68-S78.
4. Sirica AE, Campbell DJ, Dumur CI. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2011; 27: 276-84.
5. Sirica AE. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2012; 9: 44-54.
6. Okabe H, Beppu T, Hayashi H etal. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 2555-64.
7. Chuaysri C, Thuwajit P, Paupairoj A etal. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep 2009; 21: 957-69.
8. Murakami K, Abe T, Miyazawa M etal. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest 1995; 72: 731-9.
9. Xu L, Hui AY, Albanis E etal. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005; 54: 142-51.
10. Okabe H, Beppu T, Hayashi H etal. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells. Ann Surg Oncol 2011; 18: 1175-84.
11. Sirica AE, Zhang Z, Lai GH etal. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines. Hepatology 2008; 47: 1178-90.
12. Dumur CI, Campbell DJ, DeWitt JL etal. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas. Exp Mol Pathol 2010; 89: 227-35.
13. Lai GH, Zhang Z, Shen XN etal. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer. Gastroenterology 2005; 129: 2047-57.
14. Sirica AE, Gainey TW. A new rat bile ductular epithelial cell culture model characterized by the appearance of polarized bile ducts in vitro. Hepatology 1997; 26: 537-49.
15. Lai GH, Radaeva S, Nakamura T etal. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver. Hepatology 2000; 31: 1257-65.
16. Ohira S, Sasaki M, Harada K etal. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interactions of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am J Pathol 2006; 168: 1155-68.
17. Irizarry RA, Bolstad BM, Collin F etal. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15.
18. Storey JD. A direct approach to false discovery rates. J R Stat Soc B 2002; 64: 479-98.
19. Sirica AE, Nathanson MH, Gores GJ etal. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference. Hepatology 2008; 48: 2040-6.
20. Park SY, Roh SJ, Kim YN etal. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 2009; 22: 649-57.
21. Esencay M, Newcomb EW, Zagzag D. HGF upregulates CXCR4 expression in gliomas via NF-κB: implications for glioma cell migration. J Neurooncol 2010; 99: 33-40.
22. Chioni A-M, Grose R. Organotypic modelling as a means of investigating epithelial-stromal interatcions during tumourigenesis. Fibrigenesis & Tissue Repair 2008; 1: 8.
23. Froeling FEM, Mirza TA, Feakins RM etal. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, β-catenin, and Ezrin expression in tumor cells. Am J Pathol 2009; 175: 636-48.
24. Froeling FEM, Marshall JF, Kocher HM. Pancreatic cancer organotypic cultures. J Biotechnol 2010; 148: 16-23.
25. De Wever O, Hendrix A, De Boeck A etal. Modeling and quantification of cancer cell invasion through collagen type I matrices. Int J Dev Biol 2010; 54: 887-96.
26. Matsumoto K, Nakamura T. Hepatocyte growth factor and the met system as a mediator of tumor-stromal interactions. Int J Cancer 2006; 119: 477-83.
27. Utispan K, Thuwajit P, Abiko Y etal. Gene expression profiling of cholangiocarcinoma-derived fibroblasts reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol Cancer 2010; 9: 13.